Information Provided By: 
Fly News Breaks for August 8, 2018
TRHC
Aug 8, 2018 | 05:18 EDT
Piper Jaffray analyst Sean Wieland raised his price target for Tabula Rasa HealthCare to $71 following the company's Q2 results and reiterates an Overweight rating on the name. The analyst raised his valuation multiple for the stock to reflect Tabula's expanded opportunity, both through the new EMTM data and the market expansion in Europe. Results from the EMTM pilots offer "solid evidence" Medwise Advisor works in an open network Medicare Part D environment, Wieland tells investors in a research note.
News For TRHC From the Last 2 Days
There are no results for your query TRHC
